BSE Live
Feb 11, 16:01Prev. Close
1351.00
Open Price
1300.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 11, 15:46Prev. Close
1300.00
Open Price
1300.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of HALEOS LABS (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 13.34 | 23.76 | 6.40 | 18.46 | 0.00 | |
| Net CashFlow From Operating Activities | 13.95 | 27.26 | 8.00 | 19.66 | 0.00 | |
| Net Cash Used In Investing Activities | -13.28 | -43.27 | -6.84 | -7.53 | 0.00 | |
| Net Cash Used From Financing Activities | -2.05 | 17.60 | -0.81 | -12.34 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.38 | 1.59 | 0.36 | -0.21 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 2.03 | 0.44 | 0.08 | 0.29 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 0.65 | 2.03 | 0.44 | 0.08 | 0.00 |
17.11.2025
SMS Lifescience Consolidated September 2025 Net Sales at Rs 81.37 crore, up 3.7% Y-o-Y
12.11.2025
SMS Lifescience Standalone September 2025 Net Sales at Rs 77.84 crore, down 0.83% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017